Originally published 2020-12-20.
On 19 December 2020 India officially passed 10 million confirmed COVID-19 cases, the second country after the United States to do so. The milestone arrived at an odd moment: daily infections had been falling for three months, and some officials and modellers argued that India was close to herd immunity. That optimism did not survive. A national antibody survey soon showed that most Indians had never been infected, and a far deadlier second wave struck in April and May 2021.
This article looks at what the 10 million figure meant, why herd immunity was being discussed, what the evidence actually showed, and what India's experience teaches about reading pandemic numbers.

COVID-19 testing in India. Photo: AP Photo/Ajit Solanki
India at 10 million cases: where things stood in December 2020
India's first wave built slowly through the summer of 2020 and peaked in mid-September. On 16 September the country reported 97,894 new cases in a single day, and active cases topped one million the following day. By mid-December the daily count had dropped to roughly 25,000, and the official death toll stood at about 145,000.
Those numbers were large in absolute terms but modest for a country of more than 1.3 billion people. Experts agreed that both cases and deaths were undercounted. Testing was patchy outside the big cities, many people with mild symptoms never sought a test, and death registration in parts of the country was incomplete even before the pandemic.
Vaccination had not yet begun. India's campaign started on 16 January 2021, first for health workers and later for older adults and people with health conditions.
Why herd immunity was on the table
Herd immunity is the point at which enough people are protected, through infection or vaccination, that the virus can no longer spread easily. For the original strain of SARS-CoV-2, rough estimates put that threshold somewhere between 60 and 70 percent of a population, although the figure depends on how contagious a variant is and how long protection lasts.
In late 2020 several voices suggested India might be near that line. A committee set up by the Department of Science and Technology to build a "national supermodel" of the epidemic argued in October that the pandemic had peaked and could be under control by February 2021. Its members included mathematicians and computer scientists such as Manindra Agrawal of IIT Kanpur and M. Vidyasagar of IIT Hyderabad.
Speaking to Reuters as India crossed 10 million cases, Agrawal said the model suggested around 60 percent of Indians had already been infected, while noting that a serological survey was needed to confirm it. He added: "If the model is correct, it is unlikely that a second wave will happen, because once 60% have immunity, nothing can cause another wave."
Pradeep Awate, a senior health official in Maharashtra, also credited immunity for the falling numbers, telling Reuters: "Herd immunity is a huge part of it ... which is helping us to break the transmission."
What the antibody survey found
The confirmation never came. The Indian Council of Medical Research (ICMR) ran its third national serosurvey between 17 December 2020 and 8 January 2021, testing 28,589 people in 70 districts across 21 states. Only 21.5 percent had antibodies showing past infection.
The picture varied sharply by setting:
- Urban slums: 31.7 percent
- Other urban areas: 26.2 percent
- Rural areas: 19.1 percent
Even allowing for antibodies fading over time, these results were nowhere near 60 percent. ICMR's director general, Balram Bhargava, warned that a large part of the population was still susceptible. The model had also drawn criticism from epidemiologists, who noted that the committee included no epidemiologists or virologists and that its assumptions were hard to test.
The second wave proved the forecast wrong
By early April 2021 cases were climbing again, driven in large part by the more transmissible Delta variant first identified in India. In late April the country was averaging around 300,000 new cases a day, and on 30 April it reported more than 400,000 in a single day. Hospitals ran out of beds and medical oxygen, and crematoriums worked around the clock.
India's official COVID-19 death toll eventually passed 530,000. The World Health Organization later estimated about 4.7 million excess deaths in India during 2020 and 2021, roughly ten times the official figure for that period. The Indian government disputed the WHO's method, but independent studies also pointed to substantial undercounting.
Why poverty and age shaped India's pandemic
Two features of Indian society influenced how the virus spread and whom it killed.
Distancing was a luxury
Working from home was possible for only a small share of workers. Millions depend on daily wages in informal jobs, and crowded housing makes isolation difficult, which helps explain why infection rates were highest in urban slums. Direct support was also harder to deliver to people outside the formal economy, although financial inclusion had grown quickly: by 2017 about 80 percent of Indian adults had a bank account, according to the World Bank's Global Findex survey (source).
A younger population
COVID-19 mortality rises steeply with age. India's median age is far lower than that of most European countries or the United States, which helps explain why its reported death rate in 2020 looked low compared with wealthier, older nations. Undercounting played a part too, so the comparison should be read with care.
Common myths about herd immunity, and what we learned
Myth: falling cases mean immunity has been reached. Case counts fall for many reasons, including seasonal patterns, behaviour changes, testing levels and local outbreaks burning out. Only population antibody surveys, repeated over time, can show how many people have actually been infected.
Myth: one infection gives lasting protection. Immunity after COVID-19 wanes, and new variants can partly escape it. Delta and later Omicron reinfected many people who had already had the disease.
Myth: letting the virus spread is a shortcut. Reaching a high infection level without vaccines comes at an enormous cost in deaths and long-term illness. For comparison, the United States had recorded around 300,000 deaths by mid-December 2020, when some estimates suggested only about one in five Americans had been infected.
The practical lesson from India's experience is simple: treat a single model or a falling curve as a hypothesis, not a conclusion. Look for independent data such as serosurveys, hospital admissions and excess deaths, and listen to specialists across fields. Anyone with questions about their own COVID-19 risk or vaccination should talk to a doctor.
Sources: Wikipedia: COVID-19 pandemic in India; Down To Earth: ICMR sero survey finds antibodies in only 21.5% Indians; Scroll.in: Expert Covid committee's supermodel flounders as second wave surges; Reuters (December 2020) on India's 10 million cases; World Bank Global Findex. Photo: AP Photo/Ajit Solanki.

COMMENTS